Jennifer Stone MBA PTC Therapeutics

Jennifer Stone joined PTC Therapeutics in 2019 as Senior Vice President of Quality, overseeing all GMP, GCP, GLP, and PV quality activities. With over 25 years in the pharmaceutical industry, Jennifer has a diverse background in manufacturing and quality roles, supporting small molecules, vaccines, monoclonal antibodies, and gene therapy in both small and large pharmaceutical companies, as well as the CDMO sector. Additionally, she spent four years at the FDA’s CDER Office of Compliance, working on regulatory actions such as Warning Letters and Consent Decrees. Since 2022, Jennifer has been a member of the Rx360 Board of Directors and is currently the Chair of the Board. She holds an MBA and a bachelor’s degree in biology from the University of Maryland.